Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARISE trial of anamorelin to support postoperative adjuvant chemotherapy dose intensity in gastric cancer
jRCTs041250103Recruiting
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of anamorelin in gastric cancer (GC) (2 arms). Started Jan 2026; status: recruiting.
02
Drugs
anamorelin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on jRCTs041250103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041250103.